申请人:Pfizer, Inc.
                            
                            
                                公开号:US20030013875A1
                            
                            
                                公开(公告)日:2003-01-16
                            
                            Compounds of formula (I), their salts and prodrugs thereof, where the substituents are as defined herein are disclosed as opiate binding agents useful in the treatment of opiate-mediated conditions. Also described are processes for making such substances.
1
                            公式(I)的化合物、其盐和前药被揭示为鸦片类结合剂,可用于治疗鸦片类介导的疾病,其中取代基的定义如本文所述。还描述了制造这些物质的过程。